MoonLake Immunotherapeutics Earnings

The next earnings date for MoonLake Immunotherapeutics is November 18, 2025.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of MoonLake Immunotherapeutics Earnings

Report Date	Estimated Earnings Per Share
11/18/2025	$-0.86

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

MoonLake Immunotherapeutics Earnings: Historical

Report Date	Before/After Market	Earnings Per Share	Surprise %
05/05/2025	Before Market	$-0.63	14.34%
02/26/2025	Before Market	$-0.72	-21.46%
11/12/2024	Before Market	$-0.56	-27.27%
08/07/2024	Before Market	$-0.39	-39.29%
05/07/2024	Before Market	$-0.22	-15.79%
02/29/2024	Before Market	$-0.12	47.83%
11/14/2023	Before Market	$-0.18	21.74%
08/10/2023	Before Market	$-0.23	14.81%
05/12/2023	Before Market	$-0.23	25.81%
03/20/2023	Before Market	$-0.31	6.06%
11/14/2022	Before Market	$-0.27	15.63%
08/12/2022	After Market	$-0.34	37.04%
05/16/2022	After Market	$-0.35	---
02/17/2022	After Market	$-0.15	---
11/12/2021	---	$-0.14	---
08/16/2021	---	$-0.01	---
05/21/2021	---	$-0.01	---
03/31/2021	---	$-0.01	---
12/03/2020	---	$0	---

More About MoonLake Immunotherapeutics

Website

https://www.moonlaketx.com

Country

USA

Full Time Employees

100

MoonLake Immunotherapeutics, a clinical stage biotechnology company, focuses on developing therapies for inflammatory skin and joint diseases. It develops Sonelokimab, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody for the treatment of inflammatory diseases, as well as for hidradenitis suppurativa, psoriatic arthritis, axial spondyloarthritis, palmoplantar pustulosis, and psoriasis. The company was founded in 2021 and is headquartered in Zug, Switzerland.

“MoonLake Immunotherapeutics Earnings” Can Refer to the MoonLake Immunotherapeutics Earnings Date

Some people say “MoonLake Immunotherapeutics earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my MoonLake Immunotherapeutics position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning MoonLake Immunotherapeutics Stock on the Earnings Date

If you own MoonLake Immunotherapeutics stock (MLTX) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for MoonLake Immunotherapeutics might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading MoonLake Immunotherapeutics shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More MoonLake Immunotherapeutics Earnings

You can contact us any time if you would like to ask questions about MoonLake Immunotherapeutics earnings or anything else related to the stock market.